|
Anpha Capital buys 10 pct of Ampharco pharmaceutical
Anpha Capital, which has US$125 million invested in two Vietnamese funds, bought 10 percent of Ampharco Pharmaceutical Joint-Stock Co. on speculation growth in the industry will quicken.
The fastest economic expansion in a decade means that the 85 million Vietnamese have more disposable income to spend on health care.
Per capita income in Vietnam will probably exceed $1,000 by 2010, Prime Minister Nguyen Tan Dung said in a December speech, from about $830 at the moment.
“As the middle class continues to grow, clearly the pharmaceutical market in Vietnam will start to grow,’’ said Robert Haag, head of corporate finance at Ho Chi Minh City-based Anpha Capital.
The Southeast Asian nation’s pharmaceutical industry grew 15 percent last year, according to Anpha Capital, citing data from IMS Health Inc., a Norwalk, Connecticut-based health-research company.
Anpha Capital anticipates growth of more than that in coming years, Haag said.
Anpha Capital, which runs the Vietnam Equity Holding and Vietnam Property Holding funds, plans to increase its holding in Ampharco Pharmaceutical to about 20 percent, according to Giang Bui Cong, president of the investment fund.
The value of the 10 percent stake wasn’t disclosed.
Ampharco Pharmaceutical, which makes antibiotics and allergy drugs, should list on the stock exchange within five years, Cong said.
Gold bars stored in the HSBC vaults in London.
The price of gold set a record for a third straight day on Friday, reaching a high of US$975.90 before falling slightly to close at $971.10.
Thanhnien
|
